Member Info for inanaco

LOL

and yet Scancell is following that path which i have already explained to you is the reason why he left ...

Scancells proceeding based on licensing of the technology indeed the BioNtech deal is based on that premise

the rest of your posts is waffle .. indeed Val has not generated sensible funding, its survives on a 12 week rollover

and my posts did not explain the difficulty of the regulatory process ...

but then you would expect investors in this sector to understand that ,,,

David Evans has never reject that ... indeed he stood down because of it

every discussion has to be based around the science

Sensible Funding is only available to good science

Sensible deals are only available to good science

progression through trials is only available to good science (regulators block rubbish)

speculative posts based only around the SP which is not the science has no value

BioNtech collaboration will not have a clause "if the share price is low we will cancel project " and deal will not be Shareprice dependent how could it be

likewise CRUK, ISA Pharma,Karolinska Institutet

the issues is Knowlesi ... you are not a science passed poster ..

and Scancell is a Research based organisation ... the entire policy of scancell is to stay in that environment exactly the same as Arm Holdings ..

the reason why you can never get traction, is very very simple

You want to buy more Scancell ............. bazooka ...

FTA Canada style = pass
No Deal WTO = Pass

anything else is just remain MP's reversing the ref

Brexit is easy ..... "take back control"

if you give more back to the EU ... the Ref result fails

CU .. fails
SM fails
Mays deal fails
Norway fails
Norway Plus fails

labour policy Fails

Conservative manifesto PASS

Ray

which is why i based my calculations on the cost of failure of Pd-1 .. we know that 30% of patients gain Benefit which means the NHS is paying for the 70% that didn't

You cannot value sales without Efficacy .. you can only guess as efficacy indicates the price you can charge and if you achieve the Gold standard of "standard of care"

the only thing that has efficacy is SCIB1 in the adjuvant setting and solid tumor without checkpoint ..

so can you please provide the Nice Calculations that would generated a pricing structure acceptable by Nice as confirmatory to the Trinity statements rather than a brokers "stab in the dark formula"

that would then give a true sales figure from an actual market the NHS

price, patient numbers , efficacy, cost of side effects, cost of administration ie doctors time/nurse = potential sales value

that is the algorithm

Thank you Mr Ruck

how odd ...

we are all here waiting for a deal ... which could yield a £3 share price

hence your tool box is missing "reason for investing part 1"

wait for a deal

what has moditope to do with SCIB1 ?

scancell considers SCIB1 its lead program for the immunobody platform

I have accepted that the issue all along has been ichor ..

they made the broken promises and in hindsight running with ver 1 gun would have been more appropriate

your trying to box me in and drag me to your level with no tool box

please visit Tool Station ... before you even attempt at having a go .. because you don't have the sophisticated knowledge in scancell to support your views

or Moditope came along and changed the situation ..

1/ citrullination

then it expanded again

2/ Homo Citrulline

then it expanded again ... TCR

add in Glycans platform

add in SCIB2

tommy your focus on £3 in context to the growth of the IP through increasing the number of shares in issue because of the above

has changed the landscape

maybe a stroll over the moors as the seasons change would help you cope with nothing remains still

I suggest we put Federer on the BOD of Ichor ... clearly he has a great return

lets sell it ?

who are you ?

Tommy don't get so carried away, you don't have a seat on the Board

not backing away from anything .. but when dealing with somebody Boring .. it's easier and more polite to just ignore ..

happy to buy and hold ....

You can do whatever you want Tommy .. ATB

1/ you cannot move the SP

Tosh has held for a deal
ONW is holding for a deal

they all expect £3

Not debating you Knowlesi .. or tommy, no point

all you have done is repeat the same posts you made last week and the week before

sorry if i wanted to listen to Parrots i would visit the zoo

at least you will always get a job in pantomime .. "pirates of penzance"

Ruckrover

History shows scancell can do deals ... indeed they sold off £5m worth of MAB's

CRUK have signed up and are paying for a trial .. its "real money"

you don't have any impact or influence for the simple reason you folded .. you gave me the information that holed your own boat ..

when money is involved others will agree with you if they are following the same buying tactic ie buy cheaper

But your influence is about the same as mine ......... I cannot move the share

I want a low share price , so does Wild Force for tax purposes, the only difference we are not trying to influence that

i have said many times a Low share has benefit if you understand the intrinsic value in the IP ... the share price is not relevant